FDA Import Refusal SCS-2430292-1/11/1 — Glaxosmithkline
The FDA refused shipment SCS-2430292-1/11/1 from Glaxosmithkline (Italy) on Nov 2, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 472,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 2, 2020
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 66VCJ99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 472,75